Life sciences shop Bioscribe works the PR beat for NanoString, the Seattle genomics company slating an initial public offering. Breast Cancer Genomics Company Eyes IPO
Tue., May 21, 2013
By Greg Hazley
Life sciences shop Bioscribe works the PR beat for NanoString, the Seattle genomics company slating an initial public offering. Read Full Story in Subscriber Area
Category: Financial PR & Investor Relations
No comments have been submitted for this story yet.